Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza A H1N1/09 Vaccine in High-risk Patients
NCT01022905Phase 4Completed
- Start
- Nov 2009
- Primary completion
- Feb 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza A H1N1 infection (H1N1). Started Nov 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01022905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022905.